←
Floris Barthel580 posts
Floris Barthel avatar

Floris Barthel

@florisbarthel

Assistant professor @TGenResearch | Postdoc @jacksonlab @MDAndersonNews | Evolutionary cancer genomics | Glioma | Telomere dysfunction | Tweets are my own

◷ Joined November 2009▧ 58 Photos and videos
Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

This is a single-center pilot and the thresholds need prospective validation. Huge credit to Shea and Sharvari, to co-senior author Ross Mangum, and to the families at Phoenix Children's. Supported by the Ivy Foundation and Students Supporting Brain Tumor Research.

Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

In one patient with high-grade glioma, tumor variants appeared in plasma as the tumor progressed on MRI. In a patient with diffuse midline glioma, the plasma fragment signal rose when leptomeningeal spread became visible on imaging.

Post attachmentPost attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

Plasma still carried prognostic information. Children with ctDNA-positive plasma after diagnosis had shorter progression-free survival (HR 4.5, adjusted for tumor type). The overall survival association weakened after adjustment.

Post attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

CSF remains the more sensitive fluid: 70% of CSF samples were ctDNA-positive, compared with 17% of plasma samples. Plasma is far easier to collect at routine visits, so better plasma detection matters for long-term monitoring.

Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

Combining the three readouts identified 38 ctDNA-positive samples out of 159. Mutations alone identified 26 and copy number alone identified 20. In two medulloblastomas with no trackable mutations, copy number profiling detected the ctDNA.

Post attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

Each sample received a composite score from three readouts: tumor-informed mutations, copy number tumor fraction and cfDNA fragment size. We set each threshold using matched germline samples. A score of 2 or more counts as ctDNA-positive.

Post attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Nov 13

We followed 28 children with medulloblastoma, diffuse midline glioma, high-grade glioma, pilocytic astrocytoma or ependymoma. The team collected 140 plasma and 27 CSF samples during clinic visits, MRI appointments and surgery.

Israel Fernandez avatar
⟳ Floris Barthel retweeted
Israel Fernandez@IsraelF96135088·Oct 23

Today is an emotional day for me. Together with Prof. John McCutcheon lab @ASU we have visualized by cryoEM what looks like a very funky ribosome from an insect endosymbiont. We believe there are important evolutionary implications. Here the pre-print: biorxiv.org/content/10.64898…

Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

Supported by a @theABTA Discovery Award, the Ivy Foundation, the Lane Spyrow GBM Fellowship and Students Supporting Brain Tumor Research. 📄 Open access in Neuro-Oncology (@NeuroOnc): doi.org/10.1093/neuonc/noag2…

Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

Together: cfDNA composition depends on tumor proliferation, the microenvironment and treatment. Interpreting a liquid biopsy in GBM will require accounting for that context. Next up: testing these principles in patient samples. Stay tuned.

Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

In mice with orthotopic GBM43 tumors, plasma cfDNA was elevated over PBS-injected controls. Separating human from mouse reads, we found tumor-derived fragments were shorter than host fragments, and their copy number profile recapitulated the parental chr7 and chr9 gains.

Post attachmentPost attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

Temozolomide (TMZ) changed the picture. In treated GBM43, cfDNA yield rose sharply and correlated with dead cell counts (R = 0.85), no longer with live cells (R = −0.04). Treated cfDNA showed nucleosomal laddering and a narrower pool of detectable variants.

Post attachmentPost attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

Fragment sizes told the same story. Astrocyte cfDNA showed a mononucleosomal peak (~185 bp) typical of apoptosis, GBM43 cfDNA lacked nucleosomal peaks, and co-cultures produced a multimodal pattern (174, 330, 486 bp) seen in neither monoculture.

Post attachment
Floris Barthel avatar
Floris Barthel@florisbarthel·Oct 6

Over 5 days, GBM43 outgrew the astrocytes and astrocyte death increased. In co-culture cfDNA, NHA-specific VAFs rose 2.4% per day while GBM43-specific VAFs fell 3.6% per day. Dying astrocytes diluted the tumor signal, much as host DNA does in patient plasma.

Post attachment